Skip to content
healthcare.dev

Prolastin-C Liquid

NDC 13533-705, Alpha1-Proteinase Inhibitor (Human), injection, solution, from GRIFOLS USA, LLC.

Product NDC
13533-705
Status
Listed
Labeler
GRIFOLS USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA103174
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13533-705 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • .ALPHA.1-PROTEINASE INHIBITOR HUMAN1000 mg/20mL

Pharmacologic classes

Human alpha-1 Proteinase Inhibitor [EPC]; Trypsin Inhibitors [MoA]

Package NDCNDC-11Package
13533-705-01135330705011 VIAL in 1 CARTON (13533-705-01) / 20 mL in 1 VIAL (13533-705-11)
13533-705-31135330705311 VIAL in 1 CARTON (13533-705-31) / 10 mL in 1 VIAL (13533-705-32)
13533-705-51135330705511 VIAL in 1 CARTON (13533-705-51) / 80 mL in 1 VIAL (13533-705-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=13533-705

Use it

Look up 13533-705 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13533-705 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13533-705. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.